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ABSTRACT
Original Scientific Article
INTRODUCTION
The mammary gland is a compound 
tubuloalveolar gland, divided into lobules by 
interlobular connective tissue. The mammary gland 
consists of parenchyma (alveoli), stroma (connective 
tissue), ducts, vessels and nerves. Bitches usually 
have ﬁ  ve pairs of glands. The cranial two pairs are 
referred to as cranial and caudal thoracic mammary 
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glands, the middle two pairs are referred to as cranial 
and caudal abdominal mammary glands, and the 
caudal pair is referred to as the inguinal mammary 
glands. After the skin, mammary gland is the second 
most common site for tumour development in dogs. 
Mammary tumours are the most frequent neoplasms 
in bitches. They represent approximately 42% of 
all tumours and 82% of those arising on the female 
reproductive organs (1, 2). 
Benign mammary tumours appear earlier in life 
than malignant ones, and younger animals usually 
present with dysplasia or hyperplasia (3). Mammary 
gland tumours are more frequently found in bitches 
at the age of 5 years and older. Many studies have 
shown that dogs with malignant tumours were 
signiﬁ  cantly older than dogs with benign tumours 
(4). Breed predisposition has been reported, but 
varies in different studies. Dachshunds, Cocker 
Spaniels, toy poodles, German Shepherds, mixed – 130
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breed dogs have been reported to have an increased 
incidence of mammary neoplasia (5). Mostly affected 
parts are caudal abdominal and inguinal mammary 
glands. Multiple tumours have been seen in 50% to 
almost 70% of dogs with mammary tumors (2, 4, 6).
In case of multiple tumours, different tumour types 
may be present within one animal. According to 
some authors 50% of the tumours are malignant, the 
majority of malignant mammary tumors in dogs are 
carcinomas and <5% are sarcomas (7). 
Group of authors have concluded that malignant 
tumours are significantly larger than benign 
tumours. Also, evidence of histological progression 
towards malignancy has been seen with increasing 
tumour size. These findings suggest that mammary 
tumours can progress from benign to malignant (4). 
The action of ovarian hormones (estrogens and 
progesterone) on mammary gland tissue during 
different stages of development is a risk factor 
associated with the development of mammary 
tumors. A preventive effect of spaying on the 
development of mammary tumors has been reported. 
Early ovariectomy in dogs and cats has a protective 
effect against both benign and malignant mammary 
tumours. (8) The risk of developing a mammary 
tumour increases as the number of estrous cycles 
increases. The risk of developing mammary gland 
tumours is 0.05% if the bitch is spayed prior to the 
first estrous cycle. An increased incidence of tumour 
development also has been observed in dogs that 
received injectable progestins for the prevention of 
estrus (9).
It has been reported that most of the dogs are 
clinically healthy when they are initially presented 
for clinical examination (2). If metastases are 
present, dogs may show nonspecific symptoms such 
as fatigue, lethargy, weight loss, dyspnoea, cough, 
lymphoedema or lameness. The extent and location 
of the metastases determines the occurrence and 
severity of the clinical signs (2, 6). Initial assessment 
of canine mammary tumour is based on basic patient 
data (age, age at ovariohysterectomy, history of 
clinical signs duration, reproductive cycles, lactation, 
synthetic progestagens therapy), general condition 
and physical examination (2, 6, 7). Surgery remains 
the basic treatment for dogs with most common type 
of mammary gland tumours (benign mixed tumor, 
adenoma, and adenocarcinoma). The adjuvant 
therapies (radiation therapy and chemotherapy) are 
used for inoperable tumours and in inflammatory 
carcinoma. The survival time after the mastectomy 
and the possibility of metastases have been reported 
as main clinical complications (10).
The aim of this retrospective study was to present 
clinical cases of canine mammary tumours recorded 
at the University Veterinary Hospital in Skopje 
in the period of two years, to evaluate the type of 
mammary tumours in the patients; to analyze the 
relationship between tumor incidence and the age of 
the patients, heat cycles and sterilization, as well as 
the survival period after surgery.
MATERIALS AND METHODS 
During a period of two years, canine patients 
have been submitted to medical and surgical 
treatment after diagnosing various types of tumours 
at the University Veterinary Hospital at the Faculty 
of veterinary medicine in Skopje. Ten patients were 
diagnosed with mammary tumours.  
Breed, age, location of the affected mammary 
glands, tumour size (maximal diameter of the 
tumour), period (in days) between the ﬁ  rst detection 
by the owners and the time the patient was brought 
for treatment, reproductive history (spaying status, 
age at spaying, whelping and history of false 
pregnancy), application of exogenous hormones 
and type of surgery (radical mastectomy) were 
obtained from review of medical records. Patients 
were thoroughly examined (assessment of general 
condition, temperature, pulse, respiration, palpation 
of the lymph nodes, CBC and serum biochemical 
proﬁ  le (ALT, AST, AP, creatinine, urea). 
After the initial examination and the lab results, 
ﬁ  ne needle aspiration (FNA) was performed using 
a 22-G needle on each mammary mass, in order 
to make the initial determination of the mass. At 
least 4 samples from different areas were obtained 
from each mass and at least 1 slide was prepared in 
a standard procedure for each aspirate. The slides 
were air-dried and stained with Diff Quick staining 
(Merck, Darmstrad, Germany) and evaluated under 
a light microscope (Nikon; 40 X magniﬁ  cation).
In addition, chest radiographs were taken before 
the planned surgical treatment. Surgical removal 
of the masses was treatment of choice (complete 
mastectomy with or without ovariohisterectomy).   
The owners were offered an adjuvant therapy 
(chemotherapy) however, none of them accepted the 
procedure due to the side effects of chemotherapy 
as well as the high price of chemotherapeutic 
medications. Histopathological examination of the 
excised tumours was performed at the Department of 
Pathology at the Faculty of Veterinary Medicine in 
Skopje. Following surgical excision, tissue samples 131
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were  ﬁ   xed in 10% formaldehyde, embedded in 
parafﬁ  n, cut into 4 μm sections, and stained with 
hematoxylin and eosin. Histological evaluation was 
performed according to the WHO classiﬁ  cation 
scheme for canine mammary tumours. Canine 
mammary tumours are histologically classiﬁ  ed into 
four categories: malignant tumours, benign tumours, 
unclassiﬁ   ed tumours, and mammary hyperplasia/
dysplasia (11).
RESULTS 
The majority of the patients (6 out of 10) with 
diagnosed mammary tumours were at the age of 
12 – 13 years. The youngest patient with mammary 
tumour was 6 years old. From a reproductive point of 
view, five of the patients with malignant mammary 
tumours have never been whelped and never treated 
with any exogenous hormones; one was treated 
with synthetic progesterone before every cycle, two 
were with unknown history. The patients were of 
different breed (Doberman Pincher, French Poodle, 
Miniature Schnauzer, Dalmatian, Cocker Spaniel, 
Irish Setter, Belgian Sheepdog and two of mixed 
breeds).  
Multiple nodular appearance of the tumour was 
found in 6 patients (Figure 1, 2), while 4 patients 
had solitary tumour mass.
In nine patients, with malignant tumors (90%), 
one was diagnosed as adenoma. Cytological 
examination of the samples (n=5) revealed lobular 
adenocarcinoma (Figure 3). Pathohistological 
examination of the mammary tumor samples (n=5) 
revealed tubuloalveolar adenocarcinoma (n=4) 
and ductal adenocarcinoma (n=1). Chest x-ray 
imaging was recommended for all patients with 
adenocarcinomas, but only 5 made it. In 3 out of 
5 of the patients with diagnosed adenocarcinoma 
lung metastases were noted by the X-ray imaging. 
Dimensions of the malignant mammary tumours 
were between 5 and 10 cm. 
The only treatment was surgical removal of 
the tumours (simple or radical mastectomy). The 
owners of seven patients agreed to additional 
ovariohysterectomy. Radical mastectomy was 
performed in patients that had multiple mammary 
tumours. Three patients died between 20 days and 
2 months after the surgery. They were presented 
in the Hospital with sings of dyspnea due to lung 
metastases, anorexia, vomiting, decreased body 
temperature and lethargy. The rest of the treated 
patients (n= 7) were monitored on a monthly basis.   
Six months after the treatment, these patients 
remained in good body condition, without any signs 
of health disorders. They are recommended and visit 
the hospital on regular check-ups every 6 months. 
Figure 1. Mammary tumour of the cranial and caudal 
abdominal mammary gland- left side (6 year old 
Doberman Pinscher) 
Figure 2. Mammary tumour on the cranial thoracal mammary gland (right) with metastases on the ingvinal mammary 
gland (9 year old Belgian Sheepdog)132
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DISCUSSION 
In this study, older dogs (12-13 years), were 
predominantly affected by mammary tumours. 
Similarly, Murphy (9) reported predominance of 
mammary tumours in bitches at the age of 10 – 11
year, and seldom before the age of 2 years (9). 
Other research group reported the highest incidence 
of mammary tumours in patients between the age 
of 6 and 10 years (up to 63%), 32% of incidence in 
patients older than 10 years and only 5% in patients 
younger than 5 years. (12)
Ovarian steroids stimulate growth of normal 
mammary tissue under physiological conditions in 
bitches. Their proliferative effect on the epithelium 
may create conditions for neoplastic proliferation (13, 
14). This occurs during every cycle and renders the 
bitch more susceptible to carcinogenesis. Oestrogens 
promote ductal growth, whereas progestins are 
able to induce a lobuloalveolar development of 
the mammary glands with hyperplasia of secretory 
and myoepithelial cells (5). Bitches that are spayed 
before the ﬁ  rst oestrus have a 0.5% risk; animals 
spayed before the second oestrus have an 8% risk, 
and those spayed after the second oestrus and before 
two and a half years of age have a 26% risk of 
developing mammary tumours compared with the 
intact ones (15). It had been reported that exogenous 
administration of progesterone derivates, which are 
used to prevent oestrus in dogs, may increase the 
incidence of canine mammary tumours. Synthetic 
progestins (such as medroxyprogesterone acetate) 
induce the same effect on the mammary gland as 
endogenous progesterone. One clinical study on 
dogs treated with medroxyprogesterone acetate 
for oestrus prevention reported a greater risk of 
Figure 3. FNA sample from canine mammary tumour (Diff Quick, 100x)
developing mammary tumours, the majority being 
malignant. (16)
In our study as well as in other studies (17, 18) 
dogs were admitted in the clinic for examination 
and treatment, roughly a year after the ﬁ  rst detection 
of the mass. In our study 6 patients (66%) were 
with multiple mammary tumours. Similarly, other 
authors reported 50% to almost 70% of multiple 
tumours in dogs with diagnosed mammary tumours 
(2, 4, 6, 19). The majority of malignant tumours 
of the mammary gland in dogs are carcinomas (7), 
in our study carcinoma was diagnosed in 89% of 
the patients. Other study has shown that dogs with 
malignant tumours were significantly older than 
dogs with benign tumours, and malignant tumors 
were significantly larger than benign tumours (4). 
Five mammary tumours were examined at the 
Department of histopathology and were diagnosed 
as carcinomas (adenocarcinoma), which is the most 
common type of canine mammary tumour. (20)
The main treatment of canine mammary 
tumours is surgery, except for inoperable highly 
metastatic disease (6, 7). Surgical excision allows 
histopathological diagnosis and can be curative 
if the margins are clean and if the cancer has not
spread (21). Dogs with benign tumours and 
approximately 50% of dogs with malignant 
mammary tumours will successfully recover if 
treated on time and depending on size of the 
tumour (22). The other 50% of the patients with 
malignant mammary tumours already has metastases 
at the time of surgery, which will eventually lead to 
death of the patient (6). The incidence of malignant 
mammary tumours in our study was 43.5%, similar 
to Moe (2001) who reported an incidence of 53.3% 
(23). Certain authors advice more radical surgery 133
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(24) because their study showed new tumour 
development in 58% of the patients in the ipsilateral 
mammary tissue after local removal of a solitary 
canine mammary tumour. In our study, radical 
mastectomy was done in 6 (66%) patients that 
had multiple mammary tumours. Literature shows 
contradicting results regarding the benefit of 
ovariectomy at the time of the excision of the 
mammary tumours (25). Only 2 patients in our 
study, with large tumor masses, were submitted to 
ovariohysterectomy and until present no signs of 
distant metastasis were detected.
 
CONCLUSION 
Mammary tumours are common tumors and 
often present in older intact female patients. Late 
diagnosis is one of the major problems that results 
in lethal outcome due to lung metastases. Dogs with 
canine mammary tumours need a full diagnostic 
work-up, and every mammary tumour should 
be excised and submitted for histopathological 
examination. Since the ovarian steroids play an 
important role in the aetiology, the most effective 
prevention of mammary tumours is elective 
ovariectomy of the bitch at an early age.
REFERENCES
1.   Moulton, J.E. (1990). Tumours of the mammary 
gland. In Moulton J.E. (Ed.), Tumours in Domestic 
Animals, (pp 518–552). Berkeley: University of 
California Press.
2.   Sorenmo K. (2003). Canine mammary gland tumors. 
Vet Clin North Am Small Anim Pract. 33, 573–596.
  http://dx.doi.org/10.1016/S0195-5616(03)00020-2
3.   Perez, A., Pena, L., Del Castillo, N., Nieto A.I. 
(2000). Factors influencing the incidence and 
prognosis of canine mammary tumours. J Small 
Anim Pract. 41, 287–291.
  http://dx.doi.org/10.1111/j.1748-5827.2000.tb03203.x
4.    Sorenmo, K.U., Kristiansen, V.M., Cofone, 
M.A., Shofer, F.S., Breen, A.M., Langeland, M., 
Mongil, C.M., Grondahl, A.M., Teige, J., Goldschmidt, 
M.H. (2009). Canine mammary gland tumours; a 
histological continuum from benign to malignant; 
clinical and histopathological evidence. Vet Comp 
Oncol. 7, 162–172.
  http://dx.doi.org/10.1111/j.1476-5829.2009.00184.x
 PMid:19691645 
 5.  Rutteman, G. R. (1990). Hormones and mammary 
tumour disease in the female dog: an update. In 
vivo. 4, 33–40.
 PMid:2103839
6. Misdorp, W. (2002). Tumours of the mammary 
gland. In: Meuten D.J. (Ed.), Tumours in Domestic 
Animals, (pp. 575–606). Ames: Iowa State Press.
http://dx.doi.org/10.1002/9780470376928.ch12
7.  MacEwen, E.G., Withrow, S. (1996). Tumours of 
the mammary gland. Small Animal Oncology. (pp. 
356–372) Philadelphia: Saunders Company.
8.  Lana, S.E., Rutteman, G.R., Withrow, S.J. (2007). 
Tumours of the mammary gland. In: Withrow S.J. 
& MacEwen B.R. (Ed.), Small Animal Clinical 
Oncology, (pp 455-477). Philadelphia: Saunders 
Company.
  http://dx.doi.org/10.1016/B978-072160558-6.50029-0
9.   Murphy, S. (2008). Mammary tumours in dogs and 
cats. In practice. 6, 334–339.
  http://dx.doi.org/10.1136/inpract.30.6.334
10. Withrow, S. J.,Vail, D. M. (2007). Small animal 
clinical oncology. Fourth edition, (pp 619–636). 
Saunders Elsevier.
11. Misdorp, W., Hellmen, E., Else, R.W. (1999). 
Mammary Tumours and dysplasia in dogs and cats.
Histologic classification of tumours of domestic 
animals. Second series (pp 3-6). Washington, DC: 
Armed Forces Institute of Pathology.
12. Zatloukal, J., Lorenzová, J., Tichy, F., Nečas, A., 
Kecová, H., Kohout, P. (2005). Breed and age as risk 
factors for canine mammary tumours. Acto Vet Brno. 
74, 103–109.
  http://dx.doi.org/10.2754/avb200574010103
13. Sorenmo, K.U., Shoferm, F.S., Goldschmidt, M.H. 
(2000). Effect of spaying and timing of spaying on 
survival of dogs with mammary carcinoma. J Vet 
Intern Med. 14, 266–270.
  http://dx.doi.org/10.1111/j.1939-1676.2000.tb01165.x
 PMid:10830539 
14.   Queiroga, F.L., Perez- Alenza, M.D., Silvan, G., 
Pena, L., Lopes, C., Illera, J.C. (2005). Role of 
steroid hormones and prolactin in canine mammary 
cancer. J Steroid Biochem Mol Biol. 94, 181–187.
  http://dx.doi.org/10.1016/j.jsbmb.2004.12.014
 PMid:15862964 
15. Schneider, R., Dorn, C.R., Taylor, D.O. (1969). 
Factors influencing canine mammary cancer 
development and postsurgical survival. J Natl Cancer 
Inst. 43, 1249–1261.
 PMid:4319248 134
Atanaskova Petrov E. et al.
Please cite this article as: Atanaskova Petrov E., Ilievska K.,Trojacanec P., Celeska I., Nikolovski G., Gjurovski G., Dovenski T. 
Canine mammary tumors - clinical survey. Mac Vet Rev 2014; 37 (2): 129-134. http://dx.doi.org/10.14432/j.macvetrev.2014.05.015
16.  Stovring, M., Moe, L., Glattre, E. (1997).  A  population-
based case-control study of canine mammary 
tumours and clinical use of medroxyprogesterone 
acetate. APMIS. 105, 590–596.
  http://dx.doi.org/10.1111/j.1699-0463.1997.tb05057.x
 PMid:9298095 
17.  Chang, S.C., Chang, C.C., Chang, T.J., Wong, M.L. 
(2005). Prognostic factors associated with survival 
two years after surgery in dogs with malignant 
mammary tumours: 79 cases (1998-2002). J Am Vet 
Med Assoc. 227, 1625-1629.
  http://dx.doi.org/10.2460/javma.2005.227.1625
 PMid:16313041 
18.   Sontasa, B.H., Ozyogurtcub, H., Gurelb, A., Ekicia, H.
(2009). Evaluation of clinical and pathological 
characteristics of 155 canines with mammary 
tumours: a retrospective study. Arch Med Vet. 41, 
53-59.
19. Benjamin, S.A., Lee, A.C., Saunders, W.J. (1999). 
Classification and behavior of canine mammary 
epithelial neoplasms based on life-span observations 
in beagles. Vet Pathol. 36, 423–436.
  http://dx.doi.org/10.1354/vp.36-5-423
 PMid:10490210 
20. Ežerskytė, A., Zamokas, G., Grigonis, A., 
Juodžiukynienė, N. (2011). The retrospective 
analyses of mammary tumours in dogs. ISSN 1392-
2130. Vet Med Zoot. 53 (75), 3-8.
21. Fossum, T.W., Hedlund, C.S. (1997). Mammary 
neoplasia. In Duncan L. (Ed.), Small Animal Surgey 
(pp. 539–544). St-Louis: Don Ladig.
22. Straw, R.C. (2005). Treatment of mammary gland 
tumours and perianal neoplasia. The North American 
Veterinary Conference (NAVC). Orlando, Florida. 
http://aleksabokarev.narod.ru/foreignarticle/14.pdf
23. Moe, L. (2001). Population-based incidence of 
mammary tumours in some dog breeds. J Reprod 
Fertil Suppl. 57, 439-43.
 PMid:11787188 
24.  Stratmann, N., Failing, K., Richter, A., Wehrend, A. 
(2008). Mammary tumour recurrence in bitches after 
regional mastectomy. Vet Surg. 37, 82–86.
  http://dx.doi.org/10.1111/j.1532-950X.2007.00351.x
 PMid:18199060 
25.  Sleeckx, N., de Rooster, H., Veldhuis Kroeze, E.J.B., 
Van Ginneken, C., Van Brantegem, L. (2011). Canine 
mammary tumours, an overview. Reprod Dom Anim. 
46, 1112–1131. 
  http://dx.doi.org/10.1111/j.1439-0531.2011.01816.x